Rain Therapeutics Inc. Common Stock Underwriting AgreementUnderwriting Agreement • April 9th, 2021 • Rain Therapeutics Inc. • Pharmaceutical preparations • New York
Rain Therapeutics Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [ 🌑 ] shares (the “Firm Shares”) and, at the election of the Underwriters, up to [ 🌑 ] additional shares (the “Optional Shares”) of Common Stock (“Stock”) of the Company (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
EXCHANGE AGREEMENTExchange Agreement • April 9th, 2021 • Rain Therapeutics Inc. • Pharmaceutical preparations
THIS EXCHANGE AGREEMENT (this “Agreement”) is made as of April [●], 2021, by and among the investors listed on Exhibit A attached hereto (each an “Investor” and together, the “Investors”) and Rain Therapeutics Inc., a Delaware corporation (the “Company”).
